A detailed history of Cetera Investment Advisers transactions in Alkermes Plc. stock. As of the latest transaction made, Cetera Investment Advisers holds 9,646 shares of ALKS stock, worth $277,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,646
Previous 10,260 5.98%
Holding current value
$277,611
Previous $247,000 8.91%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.01 - $28.55 $14,128 - $17,529
-614 Reduced 5.98%
9,646 $269,000
Q2 2024

Aug 22, 2024

BUY
$23.21 - $27.24 $3,852 - $4,521
166 Added 1.64%
10,260 $247,000
Q1 2024

May 24, 2024

BUY
$26.4 - $32.56 $266,481 - $328,660
10,094 New
10,094 $273,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.